New organization combines a trusted clinical partner to the film industry and Fortune 500 clients with a digital strategy and a prominent multi-industry leadership team
Vancouver, British Columbia–(Newsfile Corp. – July 15, 2021) – Maitri Health Technologies Corp. (CSE: MTEC) (FSE: D84) (“Maitri” or the “Company“) is pleased to announce that, further to its press release dated July 2, 2021, it has completed the acquisition of Round Hill Health Partners dba Bloom Health Partners (“Bloom“). Maitri also announces two new incoming board members: Dr. Nimisha Kalia and John Garcia.
Dr. Nimisha Kalia is currently Chief Medical Officer at GE Corporate. She is board-certified in Internal Medicine, Occupational Medicine, and Public Health and General Preventive Medicine. Among her many achievements, Dr. Kalia held academic appointments at Johns Hopkins University School of Medicine, the Johns Hopkins Bloomberg School of Public Health, and the Dell Medical School, University of Texas at Austin. She has numerous peer-reviewed publications on topics ranging from return on investment for onsite clinics to incorporating social determinant of health into workplace risk assessment. She has also consulted on occupational medicine projects for large academic hospital systems, Fortune 500 corporations and international clients in India and China.
John Garcia is a seasoned senior executive who spent 32 years in the telecom industry. He spent the last 12 years of his career at Sprint where he held pivotal roles including Chief Marketing Officer and President of Wireless before his retirement. As the 40th employee of Sprint Wireless, Mr. Garcia oversaw significant growth at the company. After leaving Sprint, he engaged in several major consulting projects, including for YRC, the nation’s largest less than truckload (LTL) carrier; VRide, a nationwide commuter van service augmenting local commuter services and Otsuka Pharmaceuticals, helping design and manage an integrated product development program for radio tracking of pill ingestion and vitals.
Current directors Hon. Tony Clement and Dr. Sam Pillersdorf will step down from their current board roles and join Maitri’s advisory board.
“We’re pleased to announce the closing of our acquisition of Bloom,” said Andrew Morton, Maitri CEO. “Both the Maitri and Bloom teams performed exceptionally in this closing and confirmed my confidence in our capabilities. We want to thank the Hon. Tony Clement and Dr. Sam Pillersdorf for the great work they’ve done as directors. We’re thrilled that they will continue as advisors as we welcome Dr. Kalia and Mr. Garcia to our board of directors. Our company is well equipped to succeed as a leader in testing, health-tech and occupational health.”
For information regarding the terms of the acquisition of Bloom, readers are encouraged to review the news release issued by the Company on July 2, 2021.
About Maitri Health Technologies
Maitri Health Technologies Corp. (CSE: MTEC) (FSE: D84) is a global platform for healthcare security. Our mission is to enhance safety and quality of life by keeping organizations and economies running. Maitri offers a system for businesses and organizations that helps engage employees and create strategies to manage health and safety. Our stable, scalable system is an integrated health-tech platform that securely manages data while delivering comprehensive workplace health and safety outcomes. For more information: https://maitrihealth.ca/
About Bloom Health
Bloom Health is a trusted occupational health and safety service provider, offering a network of top healthcare professionals and integrated laboratories for Fortune 500 companies, Hollywood productions and major sporting and music events. Bloom Health’s mission is to ensure that “unstoppable is possible” for businesses and their employees through innovative, customized healthcare models. For more information, visit www.bloomhealthpartners.com.
For more information: investors@maitrihealth.ca
On behalf of the board of directors,
MAITRI HEALTH TECHNOLOGIES CORP.
Andrew Morton, Chief Executive Officer
Forward-Looking Statements
This news release includes forward-looking statements that are subject to risks and uncertainties, including statements regarding the benefits of the Bloom Health transaction. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in the Company’s forward-looking statements include the the potential that milestones may not be satisfied, acquisitions may not achieve expected benefits, financing requirements, and the other risk factors described in the Company’s filings with Canadian securities regulators on www.sedar.com. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/90310
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…